Kentaro Hirade
Nagoya, 4648681, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
ARAF Amplification in Small-Cell Lung Cancer-Transformed Tumors Following Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.
Journal: Cancers
Published: September 18, 2024
Inhibiting KRAS with CD47 and immune checkpoint overcomes intrinsic resistance to combined KRAS and immune checkpoint inhibitor therapy.
Journal: Cell reports. Medicine
Published: May 27, 2024
Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation.
Journal: Cancer medicine
Published: June 22, 2023
Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide-treated myeloma patients.
Journal: Hematological oncology
Published: September 25, 2022
Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS.
Journal: Nature cancer
Published: July 29, 2022
A novel RARA-SNX15 fusion in PML-RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1).
Journal: International journal of hematology
Published: May 07, 2022
Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers.
Journal: Cancers
Published: September 16, 2021
Volunteer unrelated donor cell-derived acute myeloid leukemia with RUNX1-RUNX1T1.
Journal: EJHaem
Published: January 11, 2021
High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition.
Journal: Cell reports
Published: November 06, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026